Topical Roflumilast Rewrites the Safety Story by Route
Topical roflumilast shows how route of administration can rewrite a PDE4 inhibitor's safety profile, concentrating action in skin rather than circulation.
Topic
Topical Drug Delivery
Topic
Topic
Topic
Topical roflumilast shows how route of administration can rewrite a PDE4 inhibitor's safety profile, concentrating action in skin rather than circulation.